NCT04907617

Brief Summary

Adult patients who undergo surgery under general anaesthesia often experience inadvertent perioperative hypothermia. This common problem has serious consequences such as surgical site infection, coagulopathy, increased need for transfusion, altered drug metabolism and adverse cardiac events. Perioperative guidelines recommend warming the patient with a forced-air warming device and administering warmed intravenous and irrigation fluids to prevent intraoperative hypothermia. This study aims to investigate the effects of individual and combined use of intraoperative forced-air warming and warmed intravenous and irrigation fluids on postoperative body temperature, shivering, thermal comfort, pain, nausea and vomiting in adult patients receiving general anaesthesia.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2020

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 18, 2020

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

May 22, 2021

Completed
10 days until next milestone

First Posted

Study publicly available on registry

June 1, 2021

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 18, 2021

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 18, 2021

Completed
Last Updated

June 1, 2021

Status Verified

May 1, 2021

Enrollment Period

9 months

First QC Date

May 22, 2021

Last Update Submit

May 26, 2021

Conditions

Keywords

Perioperative NursingBody TemperatureHypothermiaShiveringPainPostoperative Nausea and Vomiting

Outcome Measures

Primary Outcomes (5)

  • Body temperature

    In the trial, the body temperature of the participants will be measured with a tympanic thermometer (Braun ThermoScan® 3, IRT 3030, Mexico, USA).

    two days

  • Thermal comfort scale

    The thermal comfort of the patients will be measured with a 100-point thermal comfort scale based on self-reporting. The patients will be asked to score how comfortable they are with their body temperature \[0 = extremities too cold; 50 = no discomfort (shivering or sweating); 100 = extremities too hot\] on a scale of 0-100 points (Cobb et al., 2016). This numerical rating scale has been used effectively in previous studies on thermal comfort

    two days

  • Shivering

    Shivering will be assessed using a 4-point bedside shivering assessment scale developed by Badjatia et al. (2008) \[0 = no shivering; 1 = mild (shivering localised in the neck/thorax, only visible as an artefact on EEG or can be noted on palpation); 2 = moderate (intermittent shivering in the upper extremities ± thorax); 3 = severe (diffuse shivering or continuous shivering in the upper/lower extremities)\]

    two days

  • Postoperative pain

    The postoperative pain of the patients will be assessed with the Numerical Rating Scale (NRS) based on self-reporting. The obtained NRS score will be considered as 0 = no pain, 1-3 = mild pain, 4-6 = moderate pain, 7-10 = severe pain (Chou et al., 2016; Van Dijk et al., 2012).

    two days

  • Postoperative nausea and vomiting

    Based on a previous study, the presence of postoperative nausea and vomiting of the patients in the trial will be considered as follows: 0 = no nausea; 1 = nausea without vomiting; 2 = nausea with vomiting.

    two

Study Arms (4)

G1

EXPERIMENTAL

After the induction of anaesthesia, the first group will be heated with only forced-air warming device.

Other: FAW

G2

EXPERIMENTAL

After the induction of anaesthesia, the second group will receive only warmed IV and irrigation fluids.

Other: Warmed fluids

G3

EXPERIMENTAL

After the induction of anaesthesia, forced-air warming as well as warmed IV and irrigation fluids will be applied to the third group

Other: Combination

G4

EXPERIMENTAL

After the induction of anaesthesia, the fourth group will be the control group without any intervention.

Other: Control

Interventions

FAWOTHER

After the induction of anaesthesia, for patients assigned to groups 1 and 3, the cover of the forced-air warming device (Bair HuggerTM Warming Unit, Model 505, Augustine Medical Inc., Eden Prairie, MN, USA) will be covered over the patient, with the surgical site exposed, and the temperature adjustment of the device will be set to the maximum (43°C). Then, the temperature will be adjusted to maintain a patient temperature of at least 36.5°C. When the patient's body temperature reaches 37°C, the device will be turned off and it will be restarted at a temperature measurement of \<36.5°C.

G1

In patients assigned to groups 2 and 3, intraoperative IV (Automer blood/fluid warming system, Acemedikal, South Korea) and irrigation fluids (Enthermic Warming Cabinet 1002W, Poland) will be given by heating to 37°C in a thermostatically controlled heating cabinet.

G2

After the induction of anaesthesia, for patients assigned to groups 3, the cover of the forced-air warming device (Bair HuggerTM Warming Unit, Model 505, Augustine Medical Inc., Eden Prairie, MN, USA) will be covered over the patient, with the surgical site exposed, and the temperature adjustment of the device will be set to the maximum (43°C). Then, the temperature will be adjusted to maintain a patient temperature of at least 36.5°C. When the patient's body temperature reaches 37°C, the device will be turned off and it will be restarted at a temperature measurement of \<36.5°C. In patients assigned to groups 3, intraoperative IV (Automer blood/fluid warming system, Acemedikal, South Korea) and irrigation fluids (Enthermic Warming Cabinet 1002W, Poland) will be given by heating to 37°C in a thermostatically controlled heating cabinet.

G3
ControlOTHER

The patients assigned to group 4 will only receive 'routine care'. They will not be given intraoperative forced-air warming or heated IV and irrigation fluids.

G4

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Being over the age of 18 Receiving general anesthesia, surgery time ≥ 1 hour in the American Society of Anesthesiologists (ASA) I-III class Not having any obstacle to make communication difficult İnformed written consent to participate in the study.

You may not qualify if:

  • Having surgery with local anesthesia Preoperative body temperature ≥38 0C or \<36 0C Unapplied therapeutic hypothermia during the operation, Systemic infection in the patient, Mental retardation, Serious head injury, Brain damage disruption in temperature regulation, Taking medication to affect thermoregulation Unapplied IV fluids up to one hour before anesthesia induction.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Özlem

Yozgat, Turkey (Türkiye)

RECRUITING

Related Publications (1)

  • Sahin Akboga O, Gurkan A. Effects of Active Heating Methods on Body Temperature, Shivering, Thermal Comfort, Pain, Nausea and Vomiting During General Anesthesia: A Randomized Controlled Trial. Ther Hypothermia Temp Manag. 2024 Dec;14(4):269-281. doi: 10.1089/ther.2023.0049. Epub 2023 Nov 24.

MeSH Terms

Conditions

Pain, PostoperativePostoperative Nausea and VomitingHypothermiaPain

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsNeurologic ManifestationsSigns and SymptomsNauseaSigns and Symptoms, DigestiveVomitingBody Temperature Changes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
The participants will be blinded to the trial hypothesis and design to avoid being affected by the warming intervention.
Purpose
PREVENTION
Intervention Model
FACTORIAL
Model Details: The participants in the study will be allocated to one of four groups. In the trial, the participants will be assigned to the interventions and registered by the first author of this study.After the induction of anaesthesia, forced-air warming as well as warmed IV and irrigation fluids will be applied to the first group, the second group will be heated with only forced-air warming device, the third group will receive only warmed IV and irrigation fluids, and the fourth group will be the control group without any intervention.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal İnvestigator

Study Record Dates

First Submitted

May 22, 2021

First Posted

June 1, 2021

Study Start

December 18, 2020

Primary Completion

September 18, 2021

Study Completion

December 18, 2021

Last Updated

June 1, 2021

Record last verified: 2021-05

Data Sharing

IPD Sharing
Will not share

It is not suitable for making individual participant data (IPD) available to other researchers.

Locations